Key Takeaways
- A fall from grace: Estée Lauder (NYSE: EL), owner of MAC, Clinique, La Mer, Jo Malone and The Ordinary, saw its shares collapse roughly 75% from their early-2022 peak as China demand, Asian travel retail and its own missteps caught up with it.
- The turnaround is showing up in the numbers: fiscal 2026 (ended June) delivered sales up 5% to $15 billion, the first organic growth in three years, net income back in the black, and an operating margin up 320 basis points. Fiscal 2027 guidance points to adjusted EPS of $3.06-3.31, a big step up.
- The stock has responded, partly: EL is up around 45% over the past year to about $96, with a recent Raymond James upgrade to Strong Buy, yet it still trades far below its old highs, and most analysts remain on Hold.
- India is the new growth engine: EL is buying full ownership of Forest Essentials, India's top prestige skincare brand, a deal that will make India its largest emerging market, while rival L'Oréal pours money into Indian brands and a $383 million Hyderabad tech hub. India's beauty market is growing around 15% a year.
- The takeaway: a genuine turnaround with real momentum, but a stretched consumer, a fragile China, painful restructuring and a no-longer-cheap earnings multiple mean the hard part isn't over.
- Research it your way: you can invest in global stocks and ETFs from just $1 with zero commission on the Nemo.money app.
Introduction
Few corporate falls have been as dramatic as Estée Lauder's. The company behind MAC lipsticks, Clinique moisturisers, La Mer creams and Jo Malone candles was a pandemic-era stock market darling, then lost roughly three-quarters of its value as Chinese demand faded, its travel-retail machine seized up, and nimbler rivals stole the TikTok generation.
Now the comeback is showing up in real numbers: sales growing again for the first time in three years, profits back, margins rebuilding, and a new CEO ripping up the old playbook. And at the centre of the next chapter is a market your feed already knows well: India, where Estée Lauder is taking full ownership of the country's top prestige skincare brand and the world's beauty giants are in an open race for position.
This guide explains how beauty's biggest name fell so far, what the turnaround actually consists of, why India has become the industry's battleground, and the honest catch for anyone weighing the stock. If it prompts you to research the theme, you can explore global stocks and ETFs from just $1 with zero commission on the Nemo.money app.
People are searching:
- "Estée Lauder stock"
- "EL stock forecast"
- "Estée Lauder turnaround"
- "is Estée Lauder a good investment"
- "beauty stocks 2026"
- "Forest Essentials Estée Lauder"
- "India beauty market"
The Comeback, in Numbers
The facts, from Estée Lauder's results and filings:
- 💰 Growth is back. Fiscal 2026 (ended June) sales rose 5% to $15.05 billion, with organic growth of 3%, the first organic increase after three years of declines. Net income returned to $182 million after the prior year's heavy losses.
- 📈 Margins are rebuilding. Adjusted operating margin expanded about 320 basis points in fiscal 2026, and gross margin had already recovered to 74% from under 72% two years earlier, helped by the company's profit-recovery programme.
- 🔮 Guidance points higher. For fiscal 2027, Estée Lauder guides to organic sales growth of 3-5% and adjusted earnings of $3.06-3.31 a share, a sharp step up from fiscal 2026, as restructuring savings feed through.
- 🇨🇳 China turned first. Mainland China sales rose 11% on a reported basis in the most recent results, and the company says it outperformed the prestige beauty market there for three straight quarters, led by La Mer, Tom Ford, Le Labo and The Ordinary.
- 💄 The brands are winning again. MAC finished the year as the number-one prestige makeup brand in the US, skincare grew 4% organically to $7.3 billion on the back of La Mer and The Ordinary, and Le Labo and Jo Malone London kept gaining share in fragrance.
- 📊 The market has noticed, cautiously. The stock trades around $96, up roughly 45% over the past year from a low of about $66, and Raymond James upgraded it to Strong Buy in early September with a $130 target. But most covering analysts still rate it Hold, and the shares remain far below their early-2022 peak above $370.
How Beauty's Biggest Name Fell 75%
Understanding the collapse is the key to judging the recovery.
- 🇨🇳 Too much China, all at once. Estée Lauder rode a decade-long boom in Chinese demand for prestige skincare, especially La Mer and its namesake brand. When China's post-pandemic recovery disappointed and consumers there turned cautious, the company's biggest growth engine stalled.
- ✈️ The travel-retail trap. A huge slice of sales flowed through duty-free shops in Hainan, airports and border stores, a channel that ballooned with pandemic-era stockpiling by resellers. When it unwound, Estée Lauder was left with bloated inventories and years of painful destocking; the company has since deliberately pulled back from the channel.
- 💅 Missing the dupe generation. While Estée Lauder leaned on department stores, TikTok-native rivals like e.l.f. built businesses selling lookalikes of prestige products at a fraction of the price, and speed became the industry's currency. The company has admitted it needs the "agility, risk-taking and speed" of an indie brand.
- 📉 The financial toll. Sales fell for three straight years, profits collapsed into losses, and the stock fell from above $370 in early 2022 to about $66 at its low, wiping out roughly three-quarters of the company's value and costing thousands of jobs.
If that arc sounds familiar, it should: it's the same shape as Carnival's near-death-to-comeback story we covered this week, a giant humbled by a shock, then judged sceptically even as the numbers turn.
The Turnaround Plan, and Why It Runs Through India
Stephane de La Faverie took over as CEO in January 2025 and launched "Beauty Reimagined," a plan to make the giant behave like an indie brand: leaner, faster, closer to the consumer.
- ✂️ A painful slim-down. The restructuring has grown to a net reduction of 9,000-10,000 roles, from a workforce of about 62,000, with over 70% of the latest cuts coming from department-store counter staff as the company shifts to faster-growing channels like Ulta, Sephora, Amazon and TikTok Shop.
- 🚀 Faster launches, fewer layers. Recent hits include Clinique's SPF moisturiser line, MAC's Lipglass Air and La Mer's Balancing Treatment Lotion, and the company credits AI-driven marketing and an AI flagship for The Ordinary on China's Tmall with real impact.
- 🎯 Focus over deal-making. After a mooted combination with fragrance house Puig fell through in May, management insists the priority is growing the core brands, with one big exception below.
The India exception, and beauty's new battleground:
- 🇮🇳 Full ownership of Forest Essentials. In March, Estée Lauder agreed to buy the rest of Forest Essentials, the Ayurveda-based luxury brand it first backed in 2008, which now runs nearly 200 stores and ranks as India's top prestige skincare name. Once the deal closes later this year, the company says India will become its largest emerging market, and it plans to take "luxurious Ayurveda" global, a boom we unpacked in our deep dive on Ayurveda and the $30bn India beauty market.
- 🏁 The rivals are racing in too. L'Oréal took a majority stake in Indian personal-care group Innovist in June, announced a joint investment push with Nykaa, India's biggest beauty retailer, last week, and is building a $383 million AI beauty-tech hub in Hyderabad. With China maturing, consultants at McKinsey call India the industry's "new hot spot."
- 📈 Why the rush: India's beauty market has been growing around 15% a year toward roughly $29 billion, powered by rising incomes, premiumisation and a young, digital-first consumer, the same forces your own shopping basket in Dubai or Mumbai already reflects.
- 🌍 And the Gulf fits the same story. Prestige beauty is a mainstay of GCC malls and travel retail, and Estée Lauder's fragrance brands, Jo Malone, Tom Ford and Le Labo, play directly to the region's love of scent.
The Honest Catch
A turnaround with real numbers behind it still comes with real risks.
- 🛒 The consumer is stretched. US consumer confidence just hit a 12-year low, and prestige beauty is discretionary. The "lipstick effect", people protecting small luxuries in tough times, has limits, especially at La Mer prices.
- 🇨🇳 China's recovery is young and fragile. Three good quarters follow three terrible years, and Chinese consumer sentiment remains subdued. A relapse would hit the highest-margin part of the business.
- ⚠️ Its own guidance is hedged. The company's outlook explicitly assumes no deterioration in the geopolitical landscape, tariffs, consumer sentiment or Middle East disruptions, a long list of things currently deteriorating.
- 💅 The competition hasn't slowed. e.l.f. and other fast, cheap, viral brands keep taking share, K-beauty's $11 billion wave is reaching India and the UAE, and legacy prestige has to win back a generation that discovered dupes. Restructuring can cut costs; it can't guarantee relevance.
- 🔪 Execution risk is high. Cutting up to 10,000 roles while relaunching innovation and re-platforming distribution is corporate surgery on a grand scale, and the restructuring bill runs to hundreds of millions of dollars.
- 💲 The stock is no longer obviously cheap. At about $96, EL trades at roughly 29-31 times the midpoint of its own fiscal 2027 earnings guidance, a premium multiple that already assumes the recovery continues. It looks cheap against its own history and against L'Oréal on sales, but the easy re-rating from the $66 low has happened.
The takeaway: the market's Hold ratings aren't stubbornness. They're the price of three years of broken promises, and the burden of proof is still on the company.
What It Means for Investors
For anyone weighing beauty stocks, the balanced view:
- 🌟 A turnaround with proof, priced with scepticism. Growth, profits and margins are all moving the right way, yet most analysts sit on Hold. The research question is whether fiscal 2027 guidance is the start of a compounding recovery or the high-water mark.
- ⚖️ Know which beauty bet you're making. Estée Lauder is a prestige turnaround; L'Oréal (Paris-listed) is the steady giant; e.l.f. (NYSE: ELF) is the disruptor; Ulta (NASDAQ: ULTA) is the retailer; Coty (NYSE: COTY) skews fragrance. Each responds to different forces.
- 🇮🇳 The India theme is bigger than one stock. Direct plays like Nykaa trade in Mumbai, out of reach of US-market accounts, so most international investors research the theme through the global giants investing there, EL among them.
- 🔍 Do the work. Watch China and travel-retail commentary in the next results, the pace of restructuring charges, whether MAC and Clinique hold their US gains, and how quickly Forest Essentials scales once the deal closes.
- 💄 The backdrop matters. Beauty has historically been resilient in downturns, the "lipstick index" we've written about before, but resilience is not immunity, and the consumer data is worsening.
How to Research Beauty and Consumer Stocks with Nemo.money
Whether you're following Estée Lauder, the wider beauty theme, or turnaround stories in general, the Nemo.money app is built to help you research before you decide:
- Invest from Just $1: Fractional shares let you start small with stocks and ETFs, useful when a single EL share costs around $96.
- Zero-Commission Trading: Buy and sell US-market stocks and ETFs without commission fees.
- AI-Powered Insights & Nemes: Explore data, sentiment and curated themed collections (Nemes), including beauty and consumer themes, as a research starting point (for research, not recommendations).
- Earn 6% AER on Idle Cash: Uninvested cash in your wallet earns 6% AER, paid daily in USD, while you research and decide.
Frequently Asked Questions (FAQs)
Why did Estée Lauder stock fall so much?
Estée Lauder's shares fell roughly 75% from their early-2022 peak above $370 because the company's biggest growth engines broke at the same time. Chinese demand for prestige skincare weakened, the Asian travel-retail channel it depended on unwound painfully, leaving bloated inventories, and faster, cheaper rivals born on TikTok took share among younger consumers. Sales declined for three straight years and profits collapsed, forcing a sweeping restructuring.
Is Estée Lauder's turnaround working?
The early evidence says progress is real: fiscal 2026 delivered 5% sales growth to $15 billion, the first organic growth in three years, a return to net profit, and an operating margin up about 320 basis points, with fiscal 2027 guidance pointing to adjusted EPS of $3.06-3.31. Mainland China has outperformed for three straight quarters and MAC regained the top US prestige makeup spot. But the recovery is young, the consumer backdrop is weakening, and most analysts still rate the stock Hold.
Why is Estée Lauder buying Forest Essentials?
Estée Lauder has agreed to buy full ownership of Forest Essentials, the Ayurveda-based brand that ranks as India's top prestige skincare name, after first investing in 2008 and raising its stake to 49% in 2020. The deal, expected to close in the second half of 2026, will make India Estée Lauder's largest emerging market, and the company plans to take the brand global. It reflects an industry-wide pivot: with China maturing, India's roughly 15%-a-year beauty market growth has made it the sector's biggest prize, with L'Oréal investing heavily there too.
How can I invest in beauty stocks?
Most investors research the listed companies across the value chain: prestige houses like Estée Lauder (NYSE: EL), mass-and-viral players like e.l.f. Beauty (NYSE: ELF), retailers like Ulta Beauty (NASDAQ: ULTA), fragrance-led Coty (NYSE: COTY), and, outside the US, giants like L'Oréal in Paris. Consumer-focused ETFs offer broader exposure. Apps like Nemo.money let you research and invest in eligible US-listed stocks and ETFs from $1 with zero commission.
Is Estée Lauder a good investment?
That depends entirely on your own research, goals and risk tolerance, and this isn't advice. The bull case: a genuine turnaround with growth, profits and margins all improving, a strengthened China business, and a leading position in India's boom via Forest Essentials. The bear case: a stretched consumer, a fragile China recovery, heavy restructuring still under way, fierce competition from cheaper viral brands, and a valuation near 30 times forward earnings that already assumes success.
Final Thoughts: The Comeback Is Real. So Is the Bill.
Estée Lauder's story over four years is a lesson in how fast a great franchise can be humbled: a company built on Chinese demand, duty-free shops and department-store counters watched all three weaken at once, and lost three-quarters of its value learning that prestige is not permanence. The recovery now under way is equally instructive. It has required a new CEO, up to 10,000 job cuts, a retreat from a channel that once printed money, and a strategic pivot toward the one large beauty market still growing at double digits, India, where the company's two-decade patience with Forest Essentials is about to become full ownership.
For investors, the tension is the same one running through Carnival and gold this week: the difference between a good story and a good price. The turnaround is genuinely working, and the India bet is genuinely smart. But at roughly 30 times forward earnings, with a weakening consumer and a fragile China, the market is already paying for a fair amount of success. Whether the remaining upside justifies the remaining risk is exactly the judgement worth researching, with the next set of results, the restructuring costs and the India rollout in front of you.
Explore global stocks and ETFs from $1 with zero commission on the Nemo.money app.
Nemo = Never Miss Out.
Stay informed. Stay ahead.
#EsteeLauder #BeautyStocks #India #Investing #NemoMoney
Terms and conditions apply. This is not investment advice. Past performance is not indicative of future results. Your capital is at risk. See website for Risk Disclosure. Exinity ME Ltd (https://nemo.money) is regulated by ADGM's Financial Services Regulatory Authority.
